Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-08 Purchase | 2023-06-09 08:00 am | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 5,000 | $22.06 | $110,300 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 35,382 | $0.75 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 12,169 | $0 | 0 (Direct) | View |
| 2023-07-21 Exercise | 2023-07-24 7:44 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 5,528 | $0 | 24,126 (Direct) | View |
| 2023-07-21 Exercise | 2023-07-24 7:44 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 5,528 | $19.24 | 24,126 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 23,500 | $0 | 28,500 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-01 4:43 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 460,000 | $0 | 460,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 4:47 pm | N/A 2032-06-16 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 8,750 | $0 | 8,750 (Direct) | View |
| 2022-01-03 Option Award(A) | 2022-04-04 7:08 pm | N/A 2031-12-31 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-22 5:00 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 230,000 | $1.48 | 230,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-10 4:34 pm | N/A 2031-12-31 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 4:15 pm | N/A 2032-01-02 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 400,000 | $3.03 | 400,000 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-05 4:15 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 50,000 | $0 | 73,461 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 08:00 am | N/A 2031-02-10 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-12-08 Conversion | 2020-12-10 6:13 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO | 22,222 | $0 | 22,222 (Direct) | View |
Ownership | 2020-12-03 8:42 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO | 0 | $0 | 1,112,221 (Direct) | View |